The current fervor for GLP-1RAs in the capital markets as well as in the general public, especially in terms of weight reduction, is probably going to result in overuse, said Chun-Su Yuan, MD, PhD, the Cyrus Tang Professor of Anesthesia and Critical Care at the University of Chicago
Weight Loss Potential: Patients typically lose 15% to 22% of their total body weight
List of GLP-1 drugs Here are some FDA-approved GLP-1 receptor agonists: Semaglutide (Ozempic, Wegovy, Rybelsus) Liraglutide (Victoza, Saxenda) Dulaglutide (Trulicity) Exenatide (Byetta, Bydureon) Lixisenatide (Adlyxin) Tirzepatide (Mounjaro), technically a dual GIP/GLP-1 agonist How do GLP-1 agonists work
However, as a result of tissue-specific posttranslational processing mechanisms, different peptides are produced in the different cells
These changes give semaglutide a long half-life of about 160h , and it only needs to be injected once a week for glucose control
Acs Pharmacology & Translational Science, 2019,2(6):468-484
